Heparan sulfate-binding protein (HSBP) (HSBP)

Heparan sulfate-binding proteins (HSBPs) represent a broad functional class of proteins that interact with heparan sulfate (HS) proteoglycans, which are essential components of the cell surface and extracellular matrix (Capila & Linhardt, 2002). This group encompasses a wide variety of molecules, including growth factors like FGF and VEGF, chemokines, morphogens, and blood coagulation factors such as antithrombin III (Ori et al., 2011). The interaction with HS serves to localize these proteins, protect them from proteolysis, and facilitate their binding to high-affinity signaling receptors (Xu & Esko, 2014). In pathological states, HSBPs are often involved in promoting tumor angiogenesis, metastasis, and chronic inflammation by exploiting HS-rich environments (Knelson et al., 2014). Therapeutic intervention often involves the use of heparin or heparin-mimetics that compete for the binding sites on these proteins, thereby modulating their activity. While highly effective for anticoagulation and certain anti-inflammatory applications, targeting HSBPs carries risks such as systemic bleeding and heparin-induced thrombocytopenia due to the widespread biological roles of these interactions (Arepally, 2017).

Other names

Heparin-binding proteinsHS-binding proteinsHSBPs

Drugs typically act by mimicking the polyanionic structure of heparan sulfate to competitively inhibit protein-HS interactions, or by directly binding to the protein's heparin-binding domain to neutralize its biological activity (Capila & Linhardt, 2002).